{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T12:33:42Z","timestamp":1794400422738,"version":"4.9.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI158533"],"award-info":[{"award-number":["AI158533"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI158533"],"award-info":[{"award-number":["AI158533"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH2210494"],"award-info":[{"award-number":["W81XWH2210494"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH2210494"],"award-info":[{"award-number":["W81XWH2210494"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["BX005674"],"award-info":[{"award-number":["BX005674"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["BX005674"],"award-info":[{"award-number":["BX005674"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Antimalarial therapeutics ideally should target all three major\n                    <jats:italic>Plasmodium<\/jats:italic>\n                    life cycle stages. Here we present an acridone antimalarial chemotype that is potent against blood, liver, and mosquito stages of malaria parasites. Attributes of lead candidate T111 include potent in vitro activity against cultured parasites, ex vivo activity against clinical isolates, oral single-dose cure in an asexual blood-stage rodent model, inhibition of sexual blood-stage parasites, activity against relapsing parasites in non-human primate liver cells, prevention of parasite development in mosquitoes, and synergy in combination with tafenoquine against blood- and liver-stage parasites. Analysis of parasites selected for resistance to T111 suggests inhibition of the mitochondrial electron transport chain, with a mechanism distinct from that of other antimalarials in use or under development. The safety profile of T111, including toxicology evaluations in rats, absence of hemolytic toxicity, and low genotoxicity and cardiotoxicity potential, demonstrates a favorable therapeutic index. Overall, T111 emerges as a promising candidate for treatment and prevention of malaria, with potential for single-dose cure of bloodstream infections, radical cure of liver infections, and interruption of transmission to mosquitoes.\n                  <\/jats:p>","DOI":"10.1038\/s41467-026-71708-1","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T04:25:55Z","timestamp":1776140755000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Potent acridone antimalarial against all three life stages of Plasmodium"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6381-1236","authenticated-orcid":false,"given":"Papireddy","family":"Kancharla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rozalia A.","family":"Dodean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuexin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Charlton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angely J.","family":"Binauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6375-5019","authenticated-orcid":false,"given":"Kimberly","family":"Navarrete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurize","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6012-8389","authenticated-orcid":false,"given":"Jianbing","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghua","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Caridha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Madejczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiannu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Kudyba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"McEnearney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"Blount","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"DeLuca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chau","family":"Vuong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Pannone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hieu T.","family":"Dinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kennedy","family":"Mdaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Leed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica L.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon S.","family":"Pybus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6793-3337","authenticated-orcid":false,"given":"Geoffrey C.","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anongruk","family":"Chim-Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8338-1974","authenticated-orcid":false,"given":"Liwang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarrick","family":"Qahash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas A.","family":"Shoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3516-9829","authenticated-orcid":false,"given":"Michael T.","family":"Ferdig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank P.","family":"Mockenhaupt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3331-3997","authenticated-orcid":false,"given":"Welmoed","family":"van Loon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jules M.","family":"Ndoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Kudyba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9576-0058","authenticated-orcid":false,"given":"Joel","family":"Vega-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2712-2174","authenticated-orcid":false,"given":"Martin","family":"Okitwi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriana","family":"Kreutzfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Docan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Agulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Mirsalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah N.","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra S.","family":"Probst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Nilsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0142-2438","authenticated-orcid":false,"given":"P. Holland","family":"Alday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6098-1520","authenticated-orcid":false,"given":"J. Stone","family":"Doggett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5351-1627","authenticated-orcid":false,"given":"Geoffrey I.","family":"McFadden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3295-6683","authenticated-orcid":false,"given":"Flaminia","family":"Catteruccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7953-7622","authenticated-orcid":false,"given":"Philip J.","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1343-5279","authenticated-orcid":false,"given":"Michael K.","family":"Riscoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland A.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6917-3485","authenticated-orcid":false,"given":"Alison","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8871-0207","authenticated-orcid":false,"given":"Jane X.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"key":"71708_CR1","unstructured":"World Health Organization. World Malaria Report 2024."},{"key":"71708_CR2","doi-asserted-by":"publisher","first-page":"e1003799","DOI":"10.1371\/journal.pmed.1003799","volume":"18","author":"KE Battle","year":"2021","unstructured":"Battle, K. E. & Baird, J. K. The global burden of Plasmodium vivax malaria is obscure and insidious. PLoS Med. 18, e1003799 (2021).","journal-title":"PLoS Med"},{"key":"71708_CR3","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00109-24","volume":"37","author":"NJ White","year":"2024","unstructured":"White, N. J. & Chotivanich, K. Artemisinin-resistant malaria. Clin. Microbiol Rev. 37, e0010924 (2024).","journal-title":"Clin. Microbiol Rev."},{"key":"71708_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1001\/jama.2024.23100","volume":"333","author":"PJ Rosenthal","year":"2025","unstructured":"Rosenthal, P. J. Artemisinin partial resistance and the treatment of severe malaria. JAMA 333, 37\u201338 (2025).","journal-title":"JAMA"},{"key":"71708_CR5","doi-asserted-by":"publisher","first-page":"e1325","DOI":"10.1016\/S2214-109X(21)00216-3","volume":"9","author":"SW Lindsay","year":"2021","unstructured":"Lindsay, S. W., Thomas, M. B. & Kleinschmidt, I. Threats to the effectiveness of insecticide-treated bednets for malaria control: thinking beyond insecticide resistance. Lancet Glob. Health 9, e1325\u2013e1331 (2021).","journal-title":"Lancet Glob. Health"},{"key":"71708_CR6","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1097\/QCO.0000000000000867","volume":"35","author":"N Khan","year":"2022","unstructured":"Khan, N. & Daily, J. P. Update on pathogenesis, management, and control of Plasmodium vivax. Curr. Opin. Infect. Dis. 35, 404\u2013409 (2022).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"71708_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1146\/annurev-micro-032421-061155","volume":"75","author":"C Schafer","year":"2021","unstructured":"Schafer, C., Zanghi, G., Vaughan, A. M. & Kappe, S. H. I. Plasmodium vivax latent liver stage infection and relapse: biological insights and new experimental tools. Annu Rev. Microbiol. 75, 87\u2013106 (2021).","journal-title":"Annu Rev. Microbiol."},{"key":"71708_CR8","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.pt.2022.01.011","volume":"38","author":"LM Birkholtz","year":"2022","unstructured":"Birkholtz, L. M., Alano, P. & Leroy, D. Transmission-blocking drugs for malaria elimination. Trends Parasitol. 38, 390\u2013403 (2022).","journal-title":"Trends Parasitol."},{"key":"71708_CR9","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/s41579-024-01065-7","volume":"22","author":"PE Duffy","year":"2024","unstructured":"Duffy, P. E., Gorres, J. P., Healy, S. A. & Fried, M. Malaria vaccines: a new era of prevention and control. Nat. Rev. Microbiol. 22, 756\u2013772 (2024).","journal-title":"Nat. Rev. Microbiol."},{"key":"71708_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4269\/ajtmh.17-0869","volume":"99","author":"AA Lover","year":"2018","unstructured":"Lover, A. A., Baird, J. K., Gosling, R. & Price, R. N. Malaria elimination: time to target all species. Am. J. Trop. Med. Hyg. 99, 17\u201323 (2018).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"71708_CR11","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41573-023-00772-9","volume":"22","author":"JL Siqueira-Neto","year":"2023","unstructured":"Siqueira-Neto, J. L. et al. Antimalarial drug discovery: progress and approaches. Nat. Rev. Drug Discov. 22, 807\u2013826 (2023).","journal-title":"Nat. Rev. Drug Discov."},{"key":"71708_CR12","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1016\/S0140-6736(23)01249-7","volume":"402","author":"JR Poespoprodjo","year":"2023","unstructured":"Poespoprodjo, J. R., Douglas, N. M., Ansong, D., Kho, S. & Anstey, N. M. Malaria. Lancet 402, 2328\u20132345 (2023).","journal-title":"Lancet"},{"key":"71708_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.50","volume":"3","author":"MA Phillips","year":"2017","unstructured":"Phillips, M. A. et al. Malaria. Nat. Rev. Dis. Prim. 3, 17050 (2017).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"71708_CR14","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.pt.2024.04.015","volume":"40","author":"NM Anstey","year":"2024","unstructured":"Anstey, N. M. et al. The biology and pathogenesis of vivax malaria. Trends Parasitol. 40, 573\u2013590 (2024).","journal-title":"Trends Parasitol."},{"key":"71708_CR15","doi-asserted-by":"crossref","unstructured":"Alghamdi, J. M., Al-Qahtani, A. A., Alhamlan, F. S. & Al-Qahtani, A. A. Recent advances in the treatment of malaria. Pharmaceutics 16, 1416 (2024).","DOI":"10.3390\/pharmaceutics16111416"},{"key":"71708_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-024-05128-1","volume":"23","author":"M El Gaaloul","year":"2024","unstructured":"El Gaaloul, M. et al. Chemoprevention of malaria with long-acting oral and injectable drugs: an updated target product profile. Malar. J. 23, 315 (2024).","journal-title":"Malar. J."},{"key":"71708_CR17","doi-asserted-by":"publisher","first-page":"e1003494","DOI":"10.1371\/journal.pmed.1003494","volume":"18","author":"K Thriemer","year":"2021","unstructured":"Thriemer, K., Ley, B. & von Seidlein, L. Towards the elimination of Plasmodium vivax malaria: Implementing the radical cure. PLoS Med. 18, e1003494 (2021).","journal-title":"PLoS Med."},{"key":"71708_CR18","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1080\/14740338.2021.1859476","volume":"20","author":"CS Chu","year":"2021","unstructured":"Chu, C. S. & Hwang, J. Tafenoquine: a toxicity overview. Expert Opin. Drug Saf. 20, 349\u2013362 (2021).","journal-title":"Expert Opin. Drug Saf."},{"key":"71708_CR19","doi-asserted-by":"crossref","unstructured":"Baird, J. K. 8-Aminoquinoline therapy for latent malaria. Clin. Microbiol. Rev. 32, e00011-19 (2019).","DOI":"10.1128\/CMR.00011-19"},{"key":"71708_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-016-1675-x","volume":"16","author":"JN Burrows","year":"2017","unstructured":"Burrows, J. N. et al. New developments in anti-malarial target candidate and product profiles. Malar. J. 16, 26 (2017).","journal-title":"Malar. J."},{"key":"71708_CR21","doi-asserted-by":"publisher","first-page":"6179","DOI":"10.1021\/acs.jmedchem.0c00539","volume":"63","author":"P Kancharla","year":"2020","unstructured":"Kancharla, P. et al. Lead optimization of second-generation acridones as broad-spectrum antimalarials. J. Med. Chem. 63, 6179\u20136202 (2020).","journal-title":"J. Med. Chem."},{"key":"71708_CR22","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41579-024-01008-2","volume":"22","author":"PJ Rosenthal","year":"2024","unstructured":"Rosenthal, P. J., Asua, V. & Conrad, M. D. Emergence, transmission dynamics and mechanisms of artemisinin partial resistance in malaria parasites in Africa. Nat. Rev. Microbiol. 22, 373\u2013384 (2024).","journal-title":"Nat. Rev. Microbiol."},{"key":"71708_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-025-05481-9","volume":"24","author":"MAC Sievert","year":"2025","unstructured":"Sievert, M. A. C. et al. Measuring growth, resistance, and recovery after artemisinin treatment of Plasmodium falciparum in a single semi-high-throughput assay. Malar. J. 24, 263 (2025).","journal-title":"Malar. J."},{"key":"71708_CR24","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3201\/eid2701.203527","volume":"27","author":"C Bergmann","year":"2021","unstructured":"Bergmann, C. et al. Increase in Kelch 13 polymorphisms in Plasmodium falciparum, Southern Rwanda. Emerg. Infect. Dis. 27, 294\u2013296 (2021).","journal-title":"Emerg. Infect. Dis."},{"key":"71708_CR25","doi-asserted-by":"publisher","first-page":"852","DOI":"10.3201\/eid2804.212269","volume":"28","author":"W van Loon","year":"2022","unstructured":"van Loon, W. et al. In vitro confirmation of artemisinin resistance in Plasmodium falciparum from patient isolates, Southern Rwanda, 2019. Emerg. Infect. Dis. 28, 852\u2013855 (2022).","journal-title":"Emerg. Infect. Dis."},{"key":"71708_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44077-2","volume":"14","author":"HC Hsu","year":"2023","unstructured":"Hsu, H. C. et al. Structures revealing mechanisms of resistance and collateral sensitivity of Plasmodium falciparum to proteasome inhibitors. Nat. Commun. 14, 8302 (2023).","journal-title":"Nat. Commun."},{"key":"71708_CR27","doi-asserted-by":"crossref","unstructured":"Rasmussen, S. A. et al. Changing antimalarial drug sensitivities in Uganda. Antimicrob. Agents Chemother. 61, e01516-17 (2017).","DOI":"10.1128\/AAC.01516-17"},{"key":"71708_CR28","doi-asserted-by":"publisher","first-page":"e441","DOI":"10.1016\/S2666-5247(21)00085-9","volume":"2","author":"PK Tumwebaze","year":"2021","unstructured":"Tumwebaze, P. K. et al. Drug susceptibility of Plasmodium falciparum in eastern Uganda: a longitudinal phenotypic and genotypic study. Lancet Microbe 2, e441\u2013e449 (2021).","journal-title":"Lancet Microbe"},{"key":"71708_CR29","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/0014-4894(69)90050-2","volume":"25","author":"PE Thompson","year":"1969","unstructured":"Thompson, P. E., Bayles, A. & Olszewski, B. PAM 1392 (2,4-diamino-6-(3,4-dichlorobenzylamino) quinazoline) as a chemotherapeutic agent: Plasmodium berghei, P. cynomolgi,\u00a0P. knowlesi, and Trypanosoma cruzi. Exp. Parasitol. 25, 32\u201349 (1969).","journal-title":"Exp. Parasitol."},{"key":"71708_CR30","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.1021\/acs.jmedchem.8b01961","volume":"62","author":"RA Dodean","year":"2019","unstructured":"Dodean, R. A. et al. Discovery and structural optimization of acridones as broad-spectrum antimalarials. J. Med. Chem. 62, 3475\u20133502 (2019).","journal-title":"J. Med. Chem."},{"key":"71708_CR31","doi-asserted-by":"publisher","first-page":"8817","DOI":"10.1021\/acs.jmedchem.5c00419","volume":"68","author":"RA Dodean","year":"2025","unstructured":"Dodean, R. A. et al. Development of next-generation antimalarial acridones with radical cure potential. J. Med. Chem. 68, 8817\u20138840 (2025).","journal-title":"J. Med. Chem."},{"key":"71708_CR32","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1021\/acsinfecdis.4c00659","volume":"10","author":"A Kumar","year":"2024","unstructured":"Kumar, A. et al. Tambjamines as fast-acting multistage antimalarials. ACS Infect. Dis. 10, 4291\u20134300 (2024).","journal-title":"ACS Infect. Dis."},{"key":"71708_CR33","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.4269\/ajtmh.14-0553","volume":"92","author":"AM Stickles","year":"2015","unstructured":"Stickles, A. M. et al. Inhibition of cytochrome bc1 as a strategy for single-dose, multi-stage antimalarial therapy. Am. J. Trop. Med. Hyg. 92, 1195\u20131201 (2015).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"71708_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-73843-5","volume":"14","author":"K Miura","year":"2024","unstructured":"Miura, K. et al. A human-serum-free medium can induce more infectious P. falciparum gametocytes than a conventional human-serum-containing medium. Sci. Rep. 14, 22052 (2024).","journal-title":"Sci. Rep."},{"key":"71708_CR35","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1126\/science.aad9279","volume":"352","author":"CD Goodman","year":"2016","unstructured":"Goodman, C. D. et al. Parasites resistant to the antimalarial atovaquone fail to transmit by mosquitoes. Science 352, 349\u2013353 (2016).","journal-title":"Science"},{"key":"71708_CR36","doi-asserted-by":"crossref","unstructured":"Probst, A. S. et al. In vivo screen of Plasmodium targets for mosquito-based malaria control. Nature 643, 785\u2013793 (2025).","DOI":"10.1038\/s41586-025-09039-2"},{"key":"71708_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04221-9","volume":"9","author":"A Roth","year":"2018","unstructured":"Roth, A. et al. A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum. Nat. Commun. 9, 1837 (2018).","journal-title":"Nat. Commun."},{"key":"71708_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-10-212","volume":"10","author":"GS Dow","year":"2011","unstructured":"Dow, G. S. et al. Radical curative efficacy of tafenoquine combination regimens in Plasmodium cynomolgi-infected Rhesus monkeys (Macaca mulatta). Malar. J. 10, 212 (2011).","journal-title":"Malar. J."},{"key":"71708_CR39","doi-asserted-by":"publisher","first-page":"e18162","DOI":"10.1371\/journal.pone.0018162","volume":"6","author":"L Dembele","year":"2011","unstructured":"Dembele, L. et al. Towards an in vitro model of Plasmodium hypnozoites suitable for drug discovery. PLoS One 6, e18162 (2011).","journal-title":"PLoS One"},{"key":"71708_CR40","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1128\/AAC.03080-15","volume":"60","author":"AM Zeeman","year":"2016","unstructured":"Zeeman, A. M. et al. PI4 kinase is a prophylactic but not radical curative target in Plasmodium vivax-type malaria parasites. Antimicrob. Agents Chemother. 60, 2858\u20132863 (2016).","journal-title":"Antimicrob. Agents Chemother."},{"key":"71708_CR41","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1021\/ml500244m","volume":"5","author":"B Zou","year":"2014","unstructured":"Zou, B. et al. Lead optimization of imidazopyrazines: a new class of antimalarial with activity on Plasmodium liver stages. ACS Med. Chem. Lett. 5, 947\u2013950 (2014).","journal-title":"ACS Med. Chem. Lett."},{"key":"71708_CR42","doi-asserted-by":"publisher","first-page":"4097","DOI":"10.1128\/AAC.48.11.4097-4102.2004","volume":"48","author":"QL Fivelman","year":"2004","unstructured":"Fivelman, Q. L., Adagu, I. S. & Warhurst, D. C. Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum. Antimicrob. Agents Chemother. 48, 4097\u20134102 (2004).","journal-title":"Antimicrob. Agents Chemother."},{"key":"71708_CR43","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nature07937","volume":"459","author":"JX Kelly","year":"2009","unstructured":"Kelly, J. X. et al. Discovery of dual function acridones as a new antimalarial chemotype. Nature 459, 270\u2013273 (2009).","journal-title":"Nature"},{"key":"71708_CR44","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1128\/AAC.48.5.1803-1806.2004","volume":"48","author":"M Smilkstein","year":"2004","unstructured":"Smilkstein, M., Sriwilaijaroen, N., Kelly, J. X., Wilairat, P. & Riscoe, M. Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Antimicrob. Agents Chemother. 48, 1803\u20131806 (2004).","journal-title":"Antimicrob. Agents Chemother."},{"key":"71708_CR45","doi-asserted-by":"publisher","first-page":"360","DOI":"10.7205\/MILMED-D-16-00090","volume":"182","author":"Q Li","year":"2017","unstructured":"Li, Q. et al. Comparative susceptibility of different mouse strains to liver-stage infection with Plasmodium berghei sporozoites assessed using in vivo imaging. Mil. Med. 182, 360\u2013368 (2017).","journal-title":"Mil. Med."},{"key":"71708_CR46","doi-asserted-by":"publisher","first-page":"e7881","DOI":"10.1371\/journal.pone.0007881","volume":"4","author":"IH Ploemen","year":"2009","unstructured":"Ploemen, I. H. et al. Visualisation and quantitative analysis of the rodent malaria liver stage by real time imaging. PLoS One 4, e7881 (2009).","journal-title":"PLoS One"},{"key":"71708_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S0031182021002134","volume":"149","author":"NV Simwela","year":"2022","unstructured":"Simwela, N. V. & Waters, A. P. Current status of experimental models for the study of malaria. Parasitology 149, 1\u201322 (2022).","journal-title":"Parasitology"},{"key":"71708_CR48","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1021\/jm501809x","volume":"58","author":"V Korotchenko","year":"2015","unstructured":"Korotchenko, V. et al. Antimalarial activity of 4-amidinoquinoline and 10-amidinobenzonaphthyridine derivatives. J. Med. Chem. 58, 3411\u20133431 (2015).","journal-title":"J. Med. Chem."},{"key":"71708_CR49","doi-asserted-by":"publisher","first-page":"11746","DOI":"10.1021\/acs.jmedchem.5c00597","volume":"68","author":"A Kumar","year":"2025","unstructured":"Kumar, A. et al. Optimization of tambjamines active against multiple stages of malaria parasites. J. Med. Chem. 68, 11746\u201311785 (2025).","journal-title":"J. Med. Chem."},{"key":"71708_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-13-141","volume":"13","author":"Q Li","year":"2014","unstructured":"Li, Q. et al. Assessment of the prophylactic activity and pharmacokinetic profile of oral tafenoquine compared to primaquine for inhibition of liver stage malaria infections. Malar. J. 13, 141 (2014).","journal-title":"Malar. J."},{"key":"71708_CR51","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1093\/jac\/dks504","volume":"68","author":"GL Nixon","year":"2013","unstructured":"Nixon, G. L. et al. Antimalarial pharmacology and therapeutics of atovaquone. J. Antimicrob. Chemother. 68, 977\u2013985 (2013).","journal-title":"J. Antimicrob. Chemother."},{"key":"71708_CR52","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/0022-1759(90)90187-Z","volume":"131","author":"M Ferrari","year":"1990","unstructured":"Ferrari, M., Fornasiero, M. C. & Isetta, A. M. MTT colorimetric assay for testing macrophage cytotoxic activity in vitro. J. Immunol. Methods 131, 165\u2013172 (1990).","journal-title":"J. Immunol. Methods"},{"key":"71708_CR53","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1177\/1087057102239667","volume":"8","author":"K Schroeder","year":"2003","unstructured":"Schroeder, K., Neagle, B., Trezise, D. J. & Worley, J. Ionworks HT: a new high-throughput electrophysiology measurement platform. J. Biomol. Screen 8, 50\u201364 (2003).","journal-title":"J. Biomol. Screen"},{"key":"71708_CR54","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/0165-1161(75)90046-1","volume":"31","author":"BN Ames","year":"1975","unstructured":"Ames, B. N., Mccann, J. & Yamasaki, E. Methods for detecting carcinogens and mutagens with the Salmonella\/mammalian-microsome mutagenicity test. Mutat. Res. 31, 347\u2013364 (1975).","journal-title":"Mutat. Res."},{"key":"71708_CR55","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1159\/000452514","volume":"39","author":"A Al Mamun Bhuyan","year":"2016","unstructured":"Al Mamun Bhuyan, A., Bissinger, R., Stockinger, K. & Lang, F. Stimulation of suicidal erythrocyte death by Tafenoquine. Cell Physiol. Biochem. 39, 2464\u20132476 (2016).","journal-title":"Cell Physiol. Biochem."},{"key":"71708_CR56","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1021\/acs.jcim.0c01148","volume":"61","author":"L Jacobsen","year":"2021","unstructured":"Jacobsen, L., Husen, P. & Solov\u2019yov, I. A. Inhibition mechanism of antimalarial drugs targeting the cytochrome bc(1) complex. J. Chem. Inf. Model 61, 1334\u20131345 (2021).","journal-title":"J. Chem. Inf. Model"},{"key":"71708_CR57","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1021\/acsinfecdis.7b00276","volume":"4","author":"MR Luth","year":"2018","unstructured":"Luth, M. R., Gupta, P., Ottilie, S. & Winzeler, E. A. Using in vitro evolution and whole genome analysis to discover next generation targets for antimalarial drug discovery. ACS Infect. Dis. 4, 301\u2013314 (2018).","journal-title":"ACS Infect. Dis."},{"key":"71708_CR58","doi-asserted-by":"publisher","first-page":"17980","DOI":"10.1074\/jbc.M114.558353","volume":"289","author":"LS Ross","year":"2014","unstructured":"Ross, L. S. et al. In vitro resistance selections for Plasmodium falciparum dihydroorotate dehydrogenase inhibitors give mutants with multiple point mutations in the drug-binding site and altered growth. J. Biol. Chem. 289, 17980\u201317995 (2014).","journal-title":"J. Biol. Chem."},{"key":"71708_CR59","doi-asserted-by":"publisher","first-page":"9731","DOI":"10.1074\/jbc.M111.324319","volume":"287","author":"N Fisher","year":"2012","unstructured":"Fisher, N. et al. Cytochrome b mutation Y268S conferring atovaquone resistance phenotype in malaria parasite results in reduced parasite bc1 catalytic turnover and protein expression. J. Biol. Chem. 287, 9731\u20139741 (2012).","journal-title":"J. Biol. Chem."},{"key":"71708_CR60","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1128\/AAC.04149-14","volume":"59","author":"AM Stickles","year":"2015","unstructured":"Stickles, A. M. et al. Subtle changes in endochin-like quinolone structure alter the site of inhibition within the cytochrome bc1 complex of Plasmodium falciparum. Antimicrob. Agents Chemother. 59, 1977\u20131982 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"71708_CR61","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.molbiopara.2011.01.004","volume":"177","author":"SM Ganesan","year":"2011","unstructured":"Ganesan, S. M. et al. Yeast dihydroorotate dehydrogenase as a new selectable marker for Plasmodium falciparum transfection. Mol. Biochem. Parasitol. 177, 29\u201334 (2011).","journal-title":"Mol. Biochem. Parasitol."},{"key":"71708_CR62","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nature05572","volume":"446","author":"HJ Painter","year":"2007","unstructured":"Painter, H. J., Morrisey, J. M., Mather, M. W. & Vaidya, A. B. Specific role of mitochondrial electron transport in blood-stage Plasmodium falciparum. Nature 446, 88\u201391 (2007).","journal-title":"Nature"},{"key":"71708_CR63","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1128\/EC.05049-11","volume":"10","author":"H Ke","year":"2011","unstructured":"Ke, H. et al. Variation among Plasmodium falciparum strains in their reliance on mitochondrial electron transport chain function. Eukaryot. Cell 10, 1053\u20131061 (2011).","journal-title":"Eukaryot. Cell"},{"key":"71708_CR64","doi-asserted-by":"publisher","first-page":"4853","DOI":"10.1128\/AAC.00791-16","volume":"60","author":"AM Stickles","year":"2016","unstructured":"Stickles, A. M. et al. Atovaquone and ELQ-300 combination therapy as a novel dual-site cytochrome bc1 inhibition strategy for malaria. Antimicrob. Agents Chemother. 60, 4853\u20134859 (2016).","journal-title":"Antimicrob. Agents Chemother."},{"key":"71708_CR65","doi-asserted-by":"publisher","first-page":"6285","DOI":"10.1073\/pnas.1804492115","volume":"115","author":"KD Lane","year":"2018","unstructured":"Lane, K. D. et al. Selection of Plasmodium falciparumcytochrome B mutants by putative PfNDH2 inhibitors. Proc. Natl. Acad. Sci. USA 115, 6285\u20136290 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"71708_CR66","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.ijpara.2025.05.005","volume":"55","author":"SN Farrell","year":"2025","unstructured":"Farrell, S. N. et al. Identifying antimalarials that disrupt malaria parasite transmission when fed to the mosquito. Int J. Parasitol. 55, 603\u2013613 (2025).","journal-title":"Int J. Parasitol."},{"key":"71708_CR67","doi-asserted-by":"crossref","unstructured":"Esser, L. & Xia, D. Mitochondrial cytochrome bc(1) complex as validated drug target: a structural perspective. Trop. Med. Infect. Dis. 9, 39 (2024).","DOI":"10.3390\/tropicalmed9020039"},{"key":"71708_CR68","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1093\/jac\/dkp449","volume":"65","author":"A Nzila","year":"2010","unstructured":"Nzila, A. & Mwai, L. In vitro selection of Plasmodium falciparum drug-resistant parasite lines. J. Antimicrob. Chemother. 65, 390\u2013398 (2010).","journal-title":"J. Antimicrob. Chemother."},{"key":"71708_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-2-5","volume":"2","author":"B Schwobel","year":"2003","unstructured":"Schwobel, B., Alifrangis, M., Salanti, A. & Jelinek, T. Different mutation patterns of atovaquone resistance to Plasmodium falciparum in vitro and in vivo: rapid detection of codon 268 polymorphisms in the cytochrome b as potential in vivo resistance marker. Malar. J. 2, 5 (2003).","journal-title":"Malar. J."},{"key":"71708_CR70","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.chom.2018.01.002","volume":"23","author":"N Gural","year":"2018","unstructured":"Gural, N. et al. In vitro culture, drug sensitivity, and transcriptome of Plasmodium vivax hypnozoites. Cell Host Microbe 23, 395\u2013406.e4 (2018).","journal-title":"Cell Host Microbe"},{"key":"71708_CR71","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.chom.2015.12.001","volume":"19","author":"DM Plouffe","year":"2016","unstructured":"Plouffe, D. M. et al. High-throughput assay and discovery of small molecules that interrupt malaria transmission. Cell Host Microbe 19, 114\u2013126 (2016).","journal-title":"Cell Host Microbe"},{"key":"71708_CR72","doi-asserted-by":"crossref","unstructured":"Balta, V. A. et al. Transmissibility of clinically relevant atovaquone-resistant Plasmodium falciparum by anopheline mosquitoes. bioRxiv, 14, 6415 (2023).","DOI":"10.1101\/2023.02.07.527535"},{"key":"71708_CR73","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1021\/acsmedchemlett.5c00251","volume":"16","author":"RA Dodean","year":"2025","unstructured":"Dodean, R. A. et al. Acridone prodrugs with enhanced dual-stage antimalarial efficacy. ACS Med. Chem. Lett. 16, 1383\u20131390 (2025).","journal-title":"ACS Med. Chem. Lett."},{"key":"71708_CR74","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1093\/nar\/gkad248","volume":"51","author":"AB Lucky","year":"2023","unstructured":"Lucky, A. B. et al. Characterization of the dual role of Plasmodium falciparum DNA methyltransferase in regulating transcription and translation. Nucleic Acids Res. 51, 3918\u20133933 (2023).","journal-title":"Nucleic Acids Res"},{"key":"71708_CR75","unstructured":"National Research Council (US) Committee for the Updates of the Guide for the Care and Use of Laboratory Animals(National Academics Press, ed. 8, 2011)."},{"key":"71708_CR76","doi-asserted-by":"crossref","unstructured":"Kudyba, H. M., Cobb, D. W., Florentin, A., Krakowiak, M. & Muralidharan, V. CRISPR\/Cas9 Gene editing to make conditional mutants of human malaria parasite P. falciparum. J. Vis. Exp. 139, e57747 (2018).","DOI":"10.3791\/57747-v"},{"key":"71708_CR77","doi-asserted-by":"crossref","unstructured":"Tripathi, A. K., Mlambo, G., Kanatani, S., Sinnis, P. & Dimopoulos, G. Plasmodium falciparum gametocyte culture and mosquito infection through artificial membrane feeding. J Vis Exp, 161, e61426 (2020).","DOI":"10.3791\/61426"},{"key":"71708_CR78","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-1-62703-026-7_2","volume":"923","author":"KS Saliba","year":"2013","unstructured":"Saliba, K. S. & Jacobs-Lorena, M. Production of Plasmodium falciparum gametocytes in vitro. Methods Mol. Biol. 923, 17\u201325 (2013).","journal-title":"Methods Mol. Biol."},{"key":"71708_CR79","doi-asserted-by":"publisher","first-page":"e1006396","DOI":"10.1371\/journal.ppat.1006396","volume":"13","author":"UL Rathnapala","year":"2017","unstructured":"Rathnapala, U. L., Goodman, C. D. & McFadden, G. I. A novel genetic technique in Plasmodium berghei allows liver stage analysis of genes required for mosquito stage development and demonstrates that de novo heme synthesis is essential for liver stage development in the malaria parasite. PLoS Pathog. 13, e1006396 (2017).","journal-title":"PLoS Pathog."},{"key":"71708_CR80","doi-asserted-by":"publisher","first-page":"4133","DOI":"10.1128\/AAC.00669-07","volume":"51","author":"JX Kelly","year":"2007","unstructured":"Kelly, J. X. et al. Design, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum. Antimicrob. Agents Chemother. 51, 4133\u20134140 (2007).","journal-title":"Antimicrob. Agents Chemother."},{"key":"71708_CR81","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1159\/000479398","volume":"42","author":"A Al Mamun Bhuyan","year":"2017","unstructured":"Al Mamun Bhuyan, A., Cao, H. & Lang, F. Triggering of eryptosis, the suicidal erythrocyte death by mammalian target of rapamycin (mTOR) inhibitor Temsirolimus. Cell Physiol. Biochem 42, 1575\u20131591 (2017).","journal-title":"Cell Physiol. Biochem"},{"key":"71708_CR82","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1159\/000480469","volume":"43","author":"M Jemaa","year":"2017","unstructured":"Jemaa, M., Fezai, M., Bissinger, R. & Lang, F. Methods employed in cytofluorometric assessment of eryptosis, the suicidal erythrocyte death. Cell Physiol. Biochem. 43, 431\u2013444 (2017).","journal-title":"Cell Physiol. Biochem."},{"key":"71708_CR83","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-021-03617-1","volume":"20","author":"Y Chen","year":"2021","unstructured":"Chen, Y. et al. Selecting an anti-malarial clinical candidate from two potent dihydroisoquinolones. Malar. J. 20, 107 (2021).","journal-title":"Malar. J."},{"key":"71708_CR84","doi-asserted-by":"publisher","first-page":"296ra111","DOI":"10.1126\/scitranslmed.aaa6645","volume":"7","author":"MA Phillips","year":"2015","unstructured":"Phillips, M. A. et al. A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria. Sci. Transl. Med. 7, 296ra111 (2015).","journal-title":"Sci. Transl. Med."},{"key":"71708_CR85","doi-asserted-by":"publisher","first-page":"E5455","DOI":"10.1073\/pnas.1414221111","volume":"111","author":"MB Jimenez-Diaz","year":"2014","unstructured":"Jimenez-Diaz, M. B. et al. (+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium. Proc. Natl. Acad. Sci. USA 111, E5455\u2013E5462 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"71708_CR86","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1126\/science.7015505","volume":"212","author":"V Rosario","year":"1981","unstructured":"Rosario, V. Cloning of naturally occurring mixed infections of malaria parasites. Science 212, 1037\u20131038 (1981).","journal-title":"Science"},{"key":"71708_CR87","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357\u2013359 (2012).","journal-title":"Nat. Methods"},{"key":"71708_CR88","doi-asserted-by":"publisher","first-page":"D808","DOI":"10.1093\/nar\/gkad1003","volume":"52","author":"J Alvarez-Jarreta","year":"2024","unstructured":"Alvarez-Jarreta, J. et al. VEuPathDB: the eukaryotic pathogen, vector and host bioinformatics resource center in 2023. Nucleic Acids Res. 52, D808\u2013D816 (2024).","journal-title":"Nucleic Acids Res."},{"key":"71708_CR89","doi-asserted-by":"crossref","unstructured":"Danecek, P. et al. Twelve years of SAMtools and BCFtools. Gigascience 10, giab008 (2021).","DOI":"10.1093\/gigascience\/giab008"},{"key":"71708_CR90","unstructured":"Van der Auwera, G. A. & O'Connor, B. D. Genomics in the Cloud: Using Docker, GATK, and WDL in Terra. (O\u2019Reilly Media, 2020)."},{"key":"71708_CR91","doi-asserted-by":"publisher","first-page":"31312","DOI":"10.1074\/jbc.M304042200","volume":"278","author":"JJ Kessl","year":"2003","unstructured":"Kessl, J. J. et al. Molecular basis for atovaquone binding to the cytochrome bc1 complex. J. Biol. Chem. 278, 31312\u201331318 (2003).","journal-title":"J. Biol. Chem."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71708-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71708-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71708-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T12:03:44Z","timestamp":1794398624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71708-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["71708"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-71708-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6858328\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"assertion":[{"value":"9 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the original version of this article, the given and family names of J. Stone Doggett were incorrectly structured. The name was displayed correctly in all versions at the time of publication. The original article has been updated.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests: P.K., R.A.D., and J.X.K. are listed as inventors on a United States provisional patent application filed by Portland State University to protect the intellectual property on the acridone prodrugs described in this study. All other authors declare no competing financial or non-financial interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"4230"}}